Rxcurve
HCPCS J0770 · per 150 MG

Colistimethate sodium inj

Products billed under this code include Colistimethate Sodium.

Payment limit per 150 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J0770

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Colistimethate Sodium Hikma Pharmaceuticals Usa Inc. 00143-9443-01 1 $18.051
Colistimethate Sodium Hikma Pharmaceuticals Usa Inc. 00143-9443-12 12 $216.612
Colistimethate Sodium Heritage Pharmaceuticals Inc. 23155-0193-31 1 $18.051
Colistimethate Sodium Heritage Pharmaceuticals Inc. 23155-0193-41 12 $216.612
Colistimethate Sodium Endo USA, Inc. 42023-0107-01 1 $18.051
Colistimethate Sodium Endo USA, Inc. 42023-0131-06 6 $108.306
Colistimethate Sodium FreseniUS Kabi USA, LLC 63323-0393-06 1 $18.051
Colistimethate Sodium Xellia Pharmaceuticals USA, LLC. 70594-0023-01 1 $18.051
Colistimethate Sodium Xellia Pharmaceuticals USA, LLC. 70594-0023-04 12 $216.612
Colistimethate Sodium Xellia Pharmaceuticals USA, LLC. 70594-0023-09 1 $18.051

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $18.051 +$3.557 150 MG Colistimethate sodium inj v1, posted September 17, 2026
3Q26 $14.494 +$0.226 150 MG Colistimethate sodium inj v1, posted September 15, 2026
2Q26 $14.268 +$2.188 150 MG Colistimethate sodium inj v1, posted September 15, 2026
1Q26 $12.08 −$0.98 150 MG Colistimethate sodium inj v1, posted September 15, 2026
4Q25 $13.06 +$1.671 150 MG Colistimethate sodium inj v1, posted September 8, 2026
3Q25 $11.389 −$0.553 150 MG Colistimethate sodium inj v1, posted March 10, 2026
2Q25 $11.942 −$0.219 150 MG Colistimethate sodium inj v1, posted March 10, 2026
1Q25 $12.161 −$0.121 150 MG Colistimethate sodium inj v1, posted December 19, 2025
4Q24 $12.282 +$1.385 150 MG Colistimethate sodium inj v1, posted June 11, 2025
3Q24 $10.897 −$1.944 150 MG Colistimethate sodium inj v1, posted June 11, 2025
2Q24 $12.841 −$1.075 150 MG Colistimethate sodium inj v1, posted March 11, 2025
1Q24 $13.916 +$0.038 150 MG Colistimethate sodium inj v1, posted December 19, 2024
4Q23 $13.878 +$1.596 150 MG Colistimethate sodium inj v1, posted October 10, 2024
3Q23 $12.282 −$3.32 150 MG Colistimethate sodium inj v1, posted June 5, 2024
2Q23 $15.602 −$0.182 150 MG Colistimethate sodium inj v1, posted February 23, 2024
1Q23 $15.784 +$1.134 150 MG Colistimethate sodium inj v1, posted December 6, 2023
4Q22 $14.65 −$0.517 150 MG Colistimethate sodium inj v1, posted June 22, 2023
3Q22 $15.167 −$0.517 150 MG Colistimethate sodium inj v1, posted June 9, 2023
2Q22 $15.684 +$1.547 150 MG Colistimethate sodium inj v1, posted December 14, 2022
1Q22 $14.137 −$1.639 150 MG Colistimethate sodium inj v1, posted June 8, 2022
4Q21 $15.776 −$0.361 150 MG Colistimethate sodium inj v1, posted June 2, 2022
3Q21 $16.137 −$0.23 150 MG Colistimethate sodium inj v1, posted June 2, 2022
2Q21 $16.367 +$2.517 150 MG Colistimethate sodium inj v1, posted March 1, 2022
1Q21 $13.85 – 150 MG Colistimethate sodium inj v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files